-
br Time Lapse Microscopy br
2021-03-03
Time-Lapse Microscopy Thymidine-synchronized ovarian cells expressing mCherry-histone H2B were released for 5 hours, treated either with single agents or combinations. For time-lapse analysis, the treated cells were transferred to the microscope stage, and microscopy was performed with Axioimag
-
br Dickson RB Lippman ME Estrogenic
2021-03-03
[25] Dickson RB, Lippman ME. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 1987;8:29–43. [26] Horie K, Urano T, Ikeda K, Inoue S. Estrogen-responsive RING finger protein controls breast cancer growth. J Steroid Biochem Mol Biol 2003;
-
br temperature of solutions with different concentrations in
2021-03-03
temperature of solutions with different concentrations increased to 26.7, 34.6, 41.8, and 49.7 °C, respectively. In order to evaluate the photothermal stability of BPNs-PDA-PEG-PEITC, the 100 μg/mL solu-tion was irradiated with 808 nm NIR laser for 5 min. After turning off the NIR laser, the solut
-
br Synthesis of multifunctional PAMAM dendrimer br Synthesis
2021-03-03
2.2.1. Synthesis of multifunctional PAMAM dendrimer 2.2.1.1. Synthesis of fluorescently tagged G4 PAMAM dendrimer. Fluorescently labelled G4 PAMAM dendrimer was prepared following an earlier reported procedure with a small modification (Biswas et al., 2012). To the DMF solution of G4 dendrimer
-
br factors for developing endometrial cancer
2021-03-03
404 factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol. 407 Absolute risk of endometrial carcinoma during 20-year follow-up among women with 410 the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 416 11.F
-
br surgery was low However tracking outcomes
2021-03-02
surgery was low. However, tracking outcomes longitudinally improved the strength of our inferences by accounting for changes in functional status that occur naturally over time. Even with this sample size, we observed differences in func-tional status, minimizing the concern that this study was
-
br Cisplatin is a genotoxic
2020-08-30
Cisplatin is a genotoxic agent that is quite effective at killing HPV+ cervical cancers. Cisplatin works by inducing DNA crosslinking that activate many of the same cellular responses induced by UV exposure (McKay et al., 2001). For comparison with the UV-resistant HeLa cells, cisplatin-resistant H
-
br S Walsh D Benten S J
2020-08-30
S. Walsh, D. Benten, S.J. Forbes, R.G. Wells, J.P. Iredale, Matrix stiffness mod-ulates proliferation, chemotherapeutic response, and dormancy in hepato-cellular carcinoma cells, Hepatology 53 (2011) 1192e1205. Contents lists available at ScienceDirect Preventive Medicine journal homepage
-
br Introduction br Ovarian cancer
2020-08-30
1. Introduction Ovarian cancer is one of the most commonly occurring types of cancer and approximately 22,240 new cases of ovarian cancer will be diagnosed in the United States in 2018 (Reid et al., 2017; Siegel et al., 2018). The current standard treatment is a tumorectomy coupled with platin
-
br tients Although initial studies questioned the benefit of
2020-08-30
tients [20, 21, 25]. Although initial studies questioned the benefit of Table 2 Causes of death in older and younger patients. Older group Younger group p Table 3 Causes of death in older patients. All deceased older patients Chemo group Table 4 Demographic Informati
-
br SOX SRY HMG Box is a
2020-08-30
SOX2 (SRY HMG-Box 2) is a transcription factor that regulates oncogenic signaling pathways in different types CSCs. In human lung CSCs, a positive feedback loop between SOX2 and EGFR sustained high tumorigenic properties, and upregu-lation of SOX2 enhanced self-renewability and resistance of cance
-
br Table Primers for Real
2020-08-28
Table 1. Primers for Real-Time RT-PCR Gene Assay Number Human CAMP Human KRT20 Human TUBB1 Human TUBB3 Human FPR2 Human P2RX7 Mouse GAPDH Unisp6 Inventoried primer list of RT-PCR reactions. www.moleculartherapy.org REFERENCES 25. Rejniak, K.A. (2012). Inve
-
Triple negative breast cancer TNBC accounts for of all diagn
2020-08-28
Triple-negative breast cancer (TNBC) accounts for 10–15% of all diagnosed breast cancers and has an aggressive clinical course due to a lack of therapeutic cellular targets [1]. Accumulating clinical evidence demonstrates that TNBC is biologically more aggressive and has a higher Ki-67 proliferation
-
br Fig The structure of
2020-08-18
Fig. 1. The structure of curcumin (A) and bioconjugate AA-CUR (B). (C), Schematic illustration of the micelle formed by conjugate AA-CUR; (D), Network structure scheme of the micelle from bioconjugate AA-CUR crosslinked by Ca2+ ions. group [37,38], thus further confirming the effective conjugati
-
b iframe width height src https
2020-08-18
r> However, to the best of our knowledge, information on the epigenetic effects of BPS is lack at present. While it is too early to speculate whether the epigenetic effects of BPS is similar with BPA, the similarity in their structure and common endocrine-disruption effect warrants investigation on